Vericel Corp. VCEL shares are trading higher by $0.55 at $6.15 in Friday's session. It appears investors have turned positive on the issue following its presentation at the Ladenburg Thalman Healthcare Conference on Tuesday.
In Wednesday's session, it added $0.60 ($4.90 to $5.60) and followed that with a dime gain on Thursday to close at $5.60. Buyers came in off the open at that exact level and put in the low for the day. So far, the continuation rally has taken the issue to $6.20 and is not far off that level.
That marks the highest level for the issue since it peaked in March 2014 at $7.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
